SCHEMBL31694512

CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 8)

	gene	UniProt	supporting neighbours	confidence
▸	PTH1R	Q03431	14/20	0.71

▸	KEAP1	Q14145	1/20	0.66

▸	RXFP1	Q9HBX9	1/20	0.65

▸	GLP1R	P43220	2/20	0.61

▸	CCKBR	P32239	1/20	0.61

▸	IL23R	Q5VWK5	2/20	0.58

▸	ECE1	P42892	1/20	0.57

▸	MUS81	Q96NY9	1/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31232534	0.93	PTH1R (0.68)	PTH1RKEAP1RXFP1GLP1RCCKBR
SCHEMBL30299196	0.92	PTH1R (0.67)	PTH1RKEAP1RXFP1GLP1RCCKBR
SCHEMBL29350300	0.92	PTH1R (0.64)	PTH1RKEAP1RXFP1GLP1RCCKBR
SCHEMBL29429587	0.92	PTH1R (0.64)	PTH1RKEAP1RXFP1GLP1RCCKBR
SCHEMBL30495639	0.92	RXFP1 (0.67)	PTH1RKEAP1RXFP1GLP1RCCKBR
SCHEMBL31574199	0.91	PTH1R (0.65)	PTH1RKEAP1RXFP1GLP1RIL23R
SCHEMBL29429571	0.91	PTH1R (0.72)	PTH1RKEAP1GLP1RCCKBRIL23R
SCHEMBL30404098	0.91	PTH1R (0.72)	PTH1RKEAP1GLP1RCCKBRIL23R
SCHEMBL30028445	0.90	PTH1R (0.69)	PTH1RKEAP1RXFP1GLP1RCCKBR
SCHEMBL31694503	0.90	PTH1R (0.72)	PTH1RKEAP1RXFP1GLP1RCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-RE50618-E1	Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same	PHARMAIN CORPORATION (US)	2025-10-07	—	—	US	disclosed